Evidence map›Paper›PMID 23815982›Full record

ArticleTrends in microbiology2013

Combating enteropathogenic Escherichia coli (EPEC) infections: the way forward.

Michael S Donnenberg, B Brett Finlay

Abstract read
In one paragraph

Article in Trends in microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Virulence Factors of Enteric PathogenicInternational journal of molecular sciences · 2021
    Review
  6. Enteropathogenic Escherichia coli Infection in Cancer and Immunosuppressed Patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Intestinal cell migration damage induced by enteropathogenic Escherichia coli strains.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2018
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Microbial genomics · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael S DonnenbergUniversity of Maryland School of Medicine, 20 Penn Street, Baltimore, MD 21201, USA. mdonnenb@umaryland.edu
B Brett Finlay

Funding

Severe Enteric Disease: Pathogenesis and ResponseU19AI090873 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BOWER, DONNA ADAMS · 2010 to 2014
$7.2M
CIHRNIAID NIH HHS U19 AI 090873NIAID NIH HHS U19 AI090873
6 · The paper itself

Abstract

Enteropathogenic Escherichia coli (EPEC) strains continue to cause severe and sometimes fatal infantile diarrhea, particularly in Africa. Increased efforts at diagnosis, defining the clinical spectrum of disease, understanding pathogenic mechanisms, and delineating immune responses are desperately needed to develop new strategies to combat EPEC.

Indexed as

AfricaDiarrheaEnteropathogenic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsImmunizationVirulence FactorsEscherichia coli ProteinsVirulence Factors

Identifiers

PMID23815982
PMCPMC4312613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.